Dupilumab (Dupixent), a fully human monoclonal antibody that targets the interleukin (IL)-4 and IL-13 pathways, is currently ...
The FDA is set to give its decision on SNY and REGN's sBLA for Dupixent for chronic spontaneous urticaria on April 18, 2025.
The use of diabetes and weight-loss medications like Ozempic or Wegovy—called GLP-1 drugs—has exploded in recent years, with ...
When pain signals are passed along the nervous system, proteins called calcium channels play a key role. Researchers at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback